TNFRSF1A and neoplasm: Together, the results are consistent with a model in which TNFR1 blockade leads to intratumor DC accumulation because of decreased apoptosis, improved local antigen presentation and increased antigen-specific T cell activation, CD40-mediated positive feedback, and licensing of CD8+ T cell anti-tumor activity.